VSEE HEALTH, INC.
VSEEAnalytical Summary
VSEE HEALTH, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.
6-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Jun 24, 2024 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Mar 29, 2021 10-K ↗ |
|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) |
40.3%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+403%)
|
80.7%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+909%)
|
— | — | — | — |
| EPS Growth YoY (%) |
87.1%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-1386.8%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
39.2%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — |
| Net Income Growth YoY (%) |
74.5%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-1433.4%
Weak
Weak
Year-over-year change in net income |
-16.1%
Weak
Weak
Year-over-year change in net income |
— | — | — |
| FCF Growth YoY (%) |
69.8%
Excellent
↑
Excellent
Improving
Year-over-year change in free cash flow |
-798.4%
Weak
Weak
Year-over-year change in free cash flow |
76.7%
Excellent
Excellent
Year-over-year change in free cash flow |
— | — | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Jun 24, 2024 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Mar 29, 2021 10-K ↗ |
|---|---|---|---|---|---|---|
| Operating Margin (%) (%) |
-65.6%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-537%)
|
— |
-32.5%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-317%)
|
— | — | — |
| Effective Tax Rate (%) (%) |
-0.5%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
2.8%
Excellent
↑
Excellent
Improving
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-97.4%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
-6.1%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — |
| Profit Margin (%) (%) |
-100.6%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-939%)
|
— |
-65.3%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-644%)
|
— | — | — |
| FCF Margin (%) (%) |
-23.8%
Weak
↑
Weak
Improving
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-56.1%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-11.0%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — |
| FCF / Net Income (x) |
0.24x
Weak
→
Weak
Stable
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.10x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.17x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.43x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Jun 24, 2024 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Mar 29, 2021 10-K ↗ |
|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
-351.0%
Weak
↑
Weak
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-3123.7%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
-1681.4%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
51.4%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) |
-42.8%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-310.9%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-232.5%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-47.1%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
| Return on Common Equity (%) (%) | — | — | — |
43.7%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+191%)
|
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Jun 24, 2024 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Mar 29, 2021 10-K ↗ |
|---|---|---|---|---|---|---|
| Interest Coverage (x) |
-45.10x
Weak
↑
Weak
Improving
Operating income divided by interest expense
Optimal:
> 5x
|
-558.25x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— |
-28.54x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — |
| Net Debt (USD) | $-2.52M | $1.61M | $101.27K | $-107.00K | $-760.01K | — |
| Debt / EBITDA (x) |
-0.29x
Excellent
↓
Excellent
Declining
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
-0.03x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
-0.12x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Jun 24, 2024 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Mar 29, 2021 10-K ↗ |
|---|---|---|---|---|---|---|
| Working Capital (USD) | $-7.88M | $-15.99M | $-4.24M | $-3.19M | $1.03M | — |
| LT Debt (USD) | $2.74M | $1.93M | $220.00K | — | — | — |
| Total Equity (USD) | — | — | — | $-7.43M | $-3.33M | $0.00 |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Jun 24, 2024 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Mar 29, 2021 10-K ↗ |
|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $14.62M | $10.42M | $5.77M | — | — | — |
| Depreciation Expense (USD) | $33.61K | $17.83K | $678.00 | — | — | — |
| Net Income, GAAP (USD) | $-14.71M | $-57.70M | $-3.76M | $-3.24M | — | — |
| Operating Cash Flow (USD) | $-3.45M | $-5.79M | $-632.60K | $-1.39M | — | — |
Secondary lens
Benchmark Lens
Compare VSEE against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare VSEE against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for VSEE
No bullish signals detected
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Percentile Rankings
How VSEE compares to all companies
Peer Comparison
VSEE vs similar peers
Compare VSEE with peers
Stack VSEE against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 6 years · 22 quarters